Qvin vs Noom

Side-by-side comparison of AI visibility scores, market position, and capabilities

Noom leads in AI visibility (86 vs 34)
Qvin logo

Qvin

EmergingHealthcare

Women's Health Diagnostics & FemTech

Qvin created the Q-Pad — the world's first FDA-cleared diagnostic menstrual pad — enabling at-home lab testing using menstrual blood; tests for HbA1c (diabetes), with pipeline biomarkers for fertility, perimenopause, and thyroid health.

AI VisibilityBeta
Overall Score
D34
Category Rank
#587 of 596
AI Consensus
76%
Trend
stable
Per Platform
ChatGPT
31
Perplexity
38
Gemini
29

About

Qvin is a FemTech company revolutionizing women''s health diagnostics by using menstrual blood as a non-invasive, home-based alternative to conventional blood tests. The company''s flagship product, the Q-Pad, is the world''s first FDA-cleared diagnostic menstrual pad. Users wear the Q-Pad during their period, detach the built-in collection strip, and mail it to a CLIA-certified laboratory for clinical analysis — eliminating the need for a needle draw or clinical visit for certain health tests.

Full profile
Noom logo

Noom

GrowthHealthcare

Weight Health Platform

Noom is a digital weight health program combining psychology-based behavioral coaching, food logging, and human coaching to help members build sustainable healthy habits.

AI VisibilityBeta
Overall Score
A86
Category Rank
#12 of 596
AI Consensus
67%
Trend
stable
Per Platform
ChatGPT
80
Perplexity
81
Gemini
92

About

Noom is a digital health company founded in 2008 that has grown into one of the most widely used weight management platforms, serving millions of members through its psychology-driven approach to behavior change. The platform combines daily lessons on cognitive behavioral techniques, food logging with a traffic-light color-coding system, personal coaching from trained health coaches, and group support to help members change their relationship with food and exercise. Noom raised over $540M and reached a $3.7B valuation, establishing it as a leading consumer digital health company. The company has expanded beyond weight loss into a broader weight health platform addressing both weight management and weight-related conditions including type 2 diabetes management with its Noom Med offering that includes GLP-1 medication prescribing. As GLP-1 medications like Ozempic and Wegovy have transformed the weight loss market, Noom has positioned its behavioral coaching as essential to sustainable results alongside medication. The platform serves both direct-to-consumer subscribers and employer health plans that offer Noom as a weight management benefit for their workforces.

Full profile

AI Visibility Head-to-Head

34
Overall Score
86
#587
Category Rank
#12
76
AI Consensus
67
stable
Trend
stable
31
ChatGPT
80
38
Perplexity
81
29
Gemini
92
29
Claude
90
35
Grok
83

Key Details

Category
Women's Health Diagnostics & FemTech
Weight Health Platform
Tier
Emerging
Growth
Entity Type
brand
brand

Capabilities & Ecosystem

Capabilities

Only Noom
Weight Health Platform

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.